is tirzepatide a compounded medication Compound For Weight Loss & Metabolic Support | Rixa Health | Compound Tirzepatide | Tirzepatide Compound | Compound Tirzepatide For Weight Loss | Tirzepatide what is tirzepatide odt One

A triple agonist peptide that targets GIP, GLP-1, and glucagon receptors

Monaghan G, Clarke DJ, Povey S, See CG, Boxer M, Burchell B

But our approach goes beyond just prescribing medication

Patients eligible to enter the trial were 50 years of age or older and had established, stable, CV, cerebrovascular, peripheral artery disease, CKD or NYHA class II and III heart failure or were 60 years of age or older and had other specified risk factors for CV disease

Safety is still being characterized Without an FDA-approved label, retatrutide has no official adverse-reaction profile, boxed warnings, contraindications, or prescribing instructions